239 related articles for article (PubMed ID: 25524705)
1. The p.R482W substitution in A-type lamins deregulates SREBP1 activity in Dunnigan-type familial partial lipodystrophy.
Vadrot N; Duband-Goulet I; Cabet E; Attanda W; Barateau A; Vicart P; Gerbal F; Briand N; Vigouroux C; Oldenburg AR; Lund EG; Collas P; Buendia B
Hum Mol Genet; 2015 Apr; 24(7):2096-109. PubMed ID: 25524705
[TBL] [Abstract][Full Text] [Related]
2. The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks.
Briand N; Guénantin AC; Jeziorowska D; Shah A; Mantecon M; Capel E; Garcia M; Oldenburg A; Paulsen J; Hulot JS; Vigouroux C; Collas P
Hum Mol Genet; 2018 Apr; 27(8):1447-1459. PubMed ID: 29438482
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of Fragile X-related protein 1 by the lipodystrophic lamin A p.R482W mutation elicits a myogenic gene expression program in preadipocytes.
Oldenburg AR; Delbarre E; Thiede B; Vigouroux C; Collas P
Hum Mol Genet; 2014 Mar; 23(5):1151-62. PubMed ID: 24108105
[TBL] [Abstract][Full Text] [Related]
4. Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction.
Bidault G; Garcia M; Vantyghem MC; Ducluzeau PH; Morichon R; Thiyagarajah K; Moritz S; Capeau J; Vigouroux C; Béréziat V
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2162-71. PubMed ID: 23846499
[TBL] [Abstract][Full Text] [Related]
5. Subcellular localization of SREBP1 depends on its interaction with the C-terminal region of wild-type and disease related A-type lamins.
Duband-Goulet I; Woerner S; Gasparini S; Attanda W; Kondé E; Tellier-Lebègue C; Craescu CT; Gombault A; Roussel P; Vadrot N; Vicart P; Ostlund C; Worman HJ; Zinn-Justin S; Buendia B
Exp Cell Res; 2011 Dec; 317(20):2800-13. PubMed ID: 21993218
[TBL] [Abstract][Full Text] [Related]
6. In silico investigation of molecular mechanism of laminopathy caused by a point mutation (R482W) in lamin A/C protein.
Rajendran V; Purohit R; Sethumadhavan R
Amino Acids; 2012 Aug; 43(2):603-15. PubMed ID: 21989830
[TBL] [Abstract][Full Text] [Related]
7. Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism.
Vantyghem MC; Faivre-Defrance F; Marcelli-Tourvieille S; Fermon C; Evrard A; Bourdelle-Hego MF; Vigouroux C; Defebvre L; Delemer B; Wemeau JL
Clin Endocrinol (Oxf); 2007 Aug; 67(2):247-9. PubMed ID: 17524034
[TBL] [Abstract][Full Text] [Related]
8. Itm2a silencing rescues lamin A mediated inhibition of 3T3-L1 adipocyte differentiation.
Davies SJ; Ryan J; O'Connor PBF; Kenny E; Morris D; Baranov PV; O'Connor R; McCarthy TV
Adipocyte; 2017 Oct; 6(4):259-276. PubMed ID: 28872940
[TBL] [Abstract][Full Text] [Related]
9. A lipodystrophy-causing lamin A mutant alters conformation and epigenetic regulation of the anti-adipogenic
Oldenburg A; Briand N; Sørensen AL; Cahyani I; Shah A; Moskaug JØ; Collas P
J Cell Biol; 2017 Sep; 216(9):2731-2743. PubMed ID: 28751304
[TBL] [Abstract][Full Text] [Related]
10. A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies.
Lloyd DJ; Trembath RC; Shackleton S
Hum Mol Genet; 2002 Apr; 11(7):769-77. PubMed ID: 11929849
[TBL] [Abstract][Full Text] [Related]
11. FPLD2 LMNA mutation R482W dysregulates iPSC-derived adipocyte function and lipid metabolism.
Friesen M; Cowan CA
Biochem Biophys Res Commun; 2018 Jan; 495(1):254-260. PubMed ID: 29108996
[TBL] [Abstract][Full Text] [Related]
12. The R439C mutation in LMNA causes lamin oligomerization and susceptibility to oxidative stress.
Verstraeten VL; Caputo S; van Steensel MA; Duband-Goulet I; Zinn-Justin S; Kamps M; Kuijpers HJ; Ostlund C; Worman HJ; Briedé JJ; Le Dour C; Marcelis CL; van Geel M; Steijlen PM; van den Wijngaard A; Ramaekers FC; Broers JL
J Cell Mol Med; 2009 May; 13(5):959-71. PubMed ID: 19220582
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy.
Hegele RA; Cao H; Anderson CM; Hramiak IM
J Clin Endocrinol Metab; 2000 Sep; 85(9):3431-5. PubMed ID: 10999845
[TBL] [Abstract][Full Text] [Related]
14. Structure of the lamin A/C R482W mutant responsible for dominant familial partial lipodystrophy (FPLD).
Magracheva E; Kozlov S; Stewart CL; Wlodawer A; Zdanov A
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Jul; 65(Pt 7):665-70. PubMed ID: 19574635
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic diversity and glucocorticoid sensitivity in patients with familial partial lipodystrophy type 2.
Resende ATP; Martins CS; Bueno AC; Moreira AC; Foss-Freitas MC; de Castro M
Clin Endocrinol (Oxf); 2019 Jul; 91(1):94-103. PubMed ID: 30954027
[TBL] [Abstract][Full Text] [Related]
16. Comparison of phenotypes in male and female individuals of a new family with Dunnigan type of familial partial lipodystrophy due to a lamin A/C R482W mutation.
Laudes M; Oberhauser F; Walgenbach K; Schubert M; Schulte DM; Faust M; Krone W
Horm Metab Res; 2009 May; 41(5):414-7. PubMed ID: 19204888
[No Abstract] [Full Text] [Related]
17. A pathogenic mechanism leading to partial lipodistrophy and prospects for pharmacological treatment of insulin resistance syndrome.
Maraldi NM; Capanni C; Mattioli E; Columbaro M; Squarzoni S; Parnaik WK; Wehnert M; Lattanzi G
Acta Biomed; 2007; 78 Suppl 1():207-15. PubMed ID: 17465333
[TBL] [Abstract][Full Text] [Related]
18. LMNA missense mutations causing familial partial lipodystrophy do not lead to an accumulation of prelamin A.
Tu Y; Sánchez-Iglesias S; Araújo-Vilar D; Fong LG; Young SG
Nucleus; 2016 Sep; 7(5):512-521. PubMed ID: 27841971
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies specific for disease-associated point-mutants: lamin A/C R453W and R482W.
Roblek M; Schüchner S; Huber V; Ollram K; Vlcek-Vesely S; Foisner R; Wehnert M; Ogris E
PLoS One; 2010 May; 5(5):e10604. PubMed ID: 20498701
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene.
Garg A; Vinaitheerthan M; Weatherall PT; Bowcock AM
J Clin Endocrinol Metab; 2001 Jan; 86(1):59-65. PubMed ID: 11231979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
